ArticleCancer immunology, immunotherapy : CII2008

Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer.

Stephanie S Tseng-Rogenski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.